陶氏病
τ蛋白
神经科学
化学
Tau病理学
微管
阿尔茨海默病
疾病
神经退行性变
生物
细胞生物学
医学
病理
作者
Yan Ren,Naruhiko Sahara
标识
DOI:10.3389/fneur.2013.00102
摘要
In Alzheimer disease (AD) and other tauopathies, microtubule-associated protein tau becomes hyperphosphorylated, undergoes conformational changes, aggregates, eventually becoming neurofibrillary tangles (NFTs). As accumulating evidence suggests that NFTs themselves may not be toxic, attention is now turning toward the role of intermediate tau oligomers in AD pathophysiology. Sarkosyl extraction is a standard protocol for investigating insoluble tau aggregates in brains. There is a growing consensus that sarkosyl-insoluble tau correlates with the pathological features of tauopathy. While sarkosyl-insoluble tau from tauopathy brains has been well characterized as a pool of filamentous tau, other dimers, multimers, and granules of tau are much less well understood. There are protocols for identifying these tau oligomers. In this mini review, we discuss the characteristics of tau oligomers isolated via different methods and materials.
科研通智能强力驱动
Strongly Powered by AbleSci AI